Upcoming Events
2023 Annual Meeting of Stockholders
Virtual-Only
2023 ESMO World Congress on Gastrointestinal Cancer
Presentation Details:
Abstract Title: “The Phase 3 study Targeted Intra-Arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with Sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) trend toward a survival benefit at its first interim analysis”
Abstract Number: LBA-1
Presenting Author: Michael Jon Pishvaian, M.D., Ph.D., Director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs, Associate Professor of Oncology, John Hopkins School of Public Health
Presentation Date and Time: Thursday, June 29, 2023, at 8:50 – 9:00 AM CEST